[HTML][HTML] What do we know about frailty in the acute care setting? A scoping review
O Theou, E Squires, K Mallery, JS Lee, S Fay… - BMC geriatrics, 2018 - Springer
Background The ability of acute care providers to cope with the influx of frail older patients is
increasingly stressed, and changes need to be made to improve care provided to older …
increasingly stressed, and changes need to be made to improve care provided to older …
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial
K Rockwood, S Fay, X Song, C MacKnight, M Gorman - Cmaj, 2006 - Can Med Assoc
Background: Although cholinesterase inhibitors have produced statistically significant
treatment effects, their clinical meaningfulness in Alzheimer's disease is disputed. An important …
treatment effects, their clinical meaningfulness in Alzheimer's disease is disputed. An important …
[HTML][HTML] The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial
K Rockwood, S Fay, M Gorman, D Carver, JE Graham - BMC neurology, 2007 - Springer
Background In 6-month anti-dementia drug trials, a 4-point change in the Alzheimer's Disease
Assessment Scale-Cognitive Subscale (ADAS-Cog) is held to be clinically important. We …
Assessment Scale-Cognitive Subscale (ADAS-Cog) is held to be clinically important. We …
The ADAS‐cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease
K Rockwood, S Fay, M Gorman - … : A journal of the psychiatry of …, 2010 - Wiley Online Library
Background A minimum 4‐point change at 6 months on the Alzheimer's disease assessment
scale‐cognitive subscale (ADAS‐cog) is deemed clinically important, but this cut‐point has …
scale‐cognitive subscale (ADAS‐cog) is deemed clinically important, but this cut‐point has …
Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial
K Rockwood, S Fay, P Jarrett, E Asp - Neurology, 2007 - AAN Enterprises
… Sherri Fay and Elissa Asp have nothing to disclose. … Asp E, Cloutier F, Fay S, et al Verbal
repetition in patients with Alzheimer’s … Sherri Fay and Elissa Asp report no conflicts of interest. …
repetition in patients with Alzheimer’s … Sherri Fay and Elissa Asp report no conflicts of interest. …
Good days and bad days in dementia: a qualitative chart review of variable symptom expression
K Rockwood, S Fay, L Hamilton, E Ross… - International …, 2014 - cambridge.org
Background:Despite its importance in the lived experience of dementia, symptom fluctuation
has been little studied outside Lewy body dementia. We aimed to characterize symptom …
has been little studied outside Lewy body dementia. We aimed to characterize symptom …
[HTML][HTML] The pictorial fit-frail scale: developing a visual scale to assess frailty
…, SG Sazlina, P Moorhouse, S Fay… - Canadian Geriatrics …, 2019 - ncbi.nlm.nih.gov
Background Standardized frailty assessments are needed for early identification and
treatment. We aimed to develop a frailty scale using visual images, the Pictorial Fit-Frail Scale (…
treatment. We aimed to develop a frailty scale using visual images, the Pictorial Fit-Frail Scale (…
Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial
C Cook, S Fay, K Rockwood - International Psychogeriatrics, 2008 - cambridge.org
Background: Decreased initiation of activities is a common symptom in Alzheimer's disease (AD)
and creates significant burden for carers, yet little is known about how patients, carers …
and creates significant burden for carers, yet little is known about how patients, carers …
Verbal repetition in people with mild-to-moderate Alzheimer disease: a descriptive analysis from the VISTA Clinical Trial
C Cook, S Fay, K Rockwood - Alzheimer Disease & Associated …, 2009 - journals.lww.com
Background Verbal repetition is a common symptom and target for treatment in Alzheimer
disease (AD), yet little is known of its manifestations in the daily lives of patients. Here we …
disease (AD), yet little is known of its manifestations in the daily lives of patients. Here we …
[HTML][HTML] Treatment in a Geriatric Day Hospital improve individualized outcome measures using Goal Attainment Scaling
P Moorhouse, O Theou, S Fay, M McMillan, H Moffatt… - BMC geriatrics, 2017 - Springer
Background Evidence regarding outcomes in the Geriatric Day Hospital (GDH) model of
care has been largely inconclusive, possibly due to measurement issues. This prospective …
care has been largely inconclusive, possibly due to measurement issues. This prospective …
